Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative esketamine for postoperative recovery after orthognathic surgery
ChiCTR2600127787Phase 4Not yet recruiting
- Sponsor
- Peking University School and Hospital of Stomatology
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in Dentofacial Abnormality (2 arms), sponsored by Peking University School and Hospital of Stomatology. Primary endpoint: QoR-15 score at 24 hours after surgery. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Dentofacial Abnormality
Beyond the preview
Go deeper on ChiCTR2600127787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127787.